Published in Biores Open Access on October 01, 2014
A 3D-psoriatic skin model for dermatological testing: The impact of culture conditions. Biochem Biophys Rep (2016) 0.75
Evolving functions of endothelial cells in inflammation. Nat Rev Immunol (2007) 4.94
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood (2008) 1.83
Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis (2007) 1.77
Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol (2009) 1.49
In vivo volumetric imaging of microcirculation within human skin under psoriatic conditions using optical microangiography. Lasers Surg Med (2011) 1.34
Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis. Am J Pathol (2009) 1.32
TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. J Invest Dermatol (2011) 1.18
Diagnosis and classification of psoriasis. Autoimmun Rev (2014) 1.15
Development and validation of human psoriatic skin equivalents. Am J Pathol (2008) 1.09
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther (2004) 1.09
Angiogenesis in psoriasis. Angiogenesis (2002) 1.08
Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol (1992) 1.04
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol (2006) 0.95
Normal human epithelial cells regulate the size and morphology of tissue-engineered capillaries. Tissue Eng Part A (2010) 0.95
Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis (2013) 0.95
Investigations of the 'active' edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin. Br J Dermatol (1994) 0.95
Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Int J Immunopathol Pharmacol (2009) 0.93
The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity (2009) 0.93
Quantification of microvascular changes in the skin in patients with psoriasis. Br J Dermatol (1992) 0.93
The development and characterization of an in vitro model of psoriasis. J Invest Dermatol (2004) 0.93
A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. Tissue Eng Part A (2010) 0.92
Spontaneous fibroblast-derived pericyte recruitment in a human tissue-engineered angiogenesis model in vitro. J Cell Physiol (2012) 0.89
Angiogenesis: the new potential target for the therapy of psoriasis? Drug News Perspect (2008) 0.86
Reflectance confocal microscopy: an effective tool for monitoring ultraviolet B phototherapy in psoriasis. Br J Dermatol (2012) 0.85
In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment. Br J Dermatol (2005) 0.85
The role of endothelial cell apoptosis in the effect of etanercept in psoriasis. Br J Dermatol (2010) 0.85
Cutaneous vascular patterns in psoriasis. Int J Dermatol (2010) 0.84
Videocapillaroscopic findings in the microcirculation of the psoriatic plaque during etanercept therapy. Clin Exp Dermatol (2013) 0.84
Development of an in vitro psoriatic skin model by tissue engineering. J Dermatol Sci (2008) 0.84
Cutaneous vascular alterations in psoriatic patients treated with cyclosporine. Acta Derm Venereol (2007) 0.83
Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways. Am J Pathol (2010) 0.83
Confocal laser-scanning microscopy of capillaries in normal and psoriatic skin. J Biomed Opt (2012) 0.81
Antiangiogenic effect of methotrexate and PUVA on psoriasis. Cell Biochem Biophys (2013) 0.80
Whole field laser Doppler imaging of the microcirculation in psoriasis and clinically unaffected skin. J Dermatolog Treat (2013) 0.79
Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral Acitretin. Dermatol Res Pract (2013) 0.77
Increased endothelemia as an indirect marker of changes in the blood vessel endothelium in psoriasis. J Eur Acad Dermatol Venereol (2004) 0.76